Delta 9 Cannabis Inc (CVE:NINE) Director John William (John) Arbuthnot Iv sold 23,500 shares of the company’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of C$0.61, for a total transaction of C$14,335.00. Following the sale, the director now directly owns 14,865,500 shares of the company’s stock, valued at approximately C$9,067,955.
The stock’s fifty day moving average price is C$1.03 and its 200 day moving average price is C$1.32. Delta 9 Cannabis Inc has a twelve month low of C$0.92 and a twelve month high of C$1.75. The company has a debt-to-equity ratio of 33.00, a quick ratio of 2.04 and a current ratio of 4.44. The company has a market cap of $89.36 million and a P/E ratio of 19.07.
About Delta 9 Cannabis
Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.
Featured Story: How is the Producer Price Index calculated?
Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.